ACET
Adicet Bio, Inc.
+0.07 (+0.77%)9.12USD49.6K成交股數85.4M市值–本益比(近四季)16.4股價營收比-16.4%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.2M-31% | 1.3M-35% | 1.2M-57% | 1.4M-53% | 1.7M-42% | 2.1M | 2.7M | 3.0M | 2.9M | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 18.5M | 17.5M | 22.9M | 28.4M | 22.8M | 23.3M | 26.3M | 25.9M | 23.9M | 26.2M | 28.4M | 26.8M |
| 銷售管理費用 | 3.9M | 4.1M | 5.1M | 4.0M | 7.1M | 7.5M | 6.9M | 6.9M | 7.0M | 6.6M | 6.5M | 6.6M |
| 營業利益 | −22.3M-25% | −21.6M-30% | −28.0M-16% | −32.4M-1% | −29.9M-3% | −30.7M-41% | −33.2M-5% | −32.8M-1% | −30.9M | −52.3M | −34.9M | −33.3M |
| 營業利益率 | -1,909.3% | -1,607.3% | -2,385.0% | -2,317.0% | -1,775.7% | -1,487.3% | -1,214.4% | -1,095.3% | -1,058.0% | – | – | – |
| 稅後淨利 | −21.4M-24% | −20.2M-30% | −26.9M-12% | −31.2M+4% | −28.2M+1% | −28.7M-42% | −30.5M-6% | −29.9M-3% | −28.0M | −49.9M | −32.4M | −30.9M |
| 淨利率 | -1,828.6% | -1,508.5% | -2,291.5% | -2,233.0% | -1,676.4% | -1,389.8% | -1,116.4% | -997.0% | -960.1% | – | – | – |
| 稀釋 EPS | -1.99-60% | -1.88-91% | -0.29-15% | -5.48+1561% | -4.96+1317% | -20.31+1651% | -0.34-55% | -0.33-54% | -0.35 | -1.16 | -0.75 | -0.72 |
| 稀釋股數 | 10.7M | 10.7M | 91.1M | 5.7M | 5.7M | 5.5M | 90.8M | 90.6M | 79.1M | 43.0M | 43.0M | 43.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 33.1M | 36.2M | 29.1M | 34.7M | 28.1M | 56.5M | 105M | 224M | 160M | 183M | 205M | 232M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 148M | 169M | 140M | 163M | 191M | 220M | 246M | 269M | 293M | 233M | 278M | 305M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 28.0M | 29.3M | 31.3M | 29.6M | 29.8M | 33.6M | 34.4M | 33.7M | 34.3M | 38.6M | 38.6M | 38.8M |
| 股東權益 | 120M | 140M | 109M | 133M | 161M | 187M | 212M | 235M | 259M | 195M | 239M | 266M |
| 負債比 | 18.9% | 17.3% | 22.3% | 18.2% | 15.6% | 15.3% | 14.0% | 12.5% | 11.7% | 16.5% | 13.9% | 12.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −21.5M | – | – | −25.4M+11% | – | – | – | −22.8M | – | – | −24.1M |
| 資本支出 | – | 37K | – | – | 1.5M | – | – | – | 239K | – | – | 1.9M |
| 自由現金流 | – | −21.5M | – | – | −26.9M+16% | – | – | – | −23.1M | – | – | −26.0M |
| 折舊攤銷 | 1.2M | 1.3M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.7M | 1.6M | 1.5M | 1.3M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -1,604.1% | – | – | -1,597.7% | – | – | – | -791.2% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 5.8M | -46.1% | −117M | -2,021.9% | -16.95 | −97.0M |
| FY2024 | 10.7M | +7.4% | −117M | -1,093.2% | -21.33 | −93.5M |
| FY2023 | 10.0M | – | −143M | -1,429.7% | -3.31 | −98.2M |
| FY2022 | – | – | −69.8M | –% | -1.70 | −61.5M |
| FY2021 | – | – | −62.0M | –% | -2.00 | −64.1M |
| FY2020 | – | – | −36.7M | –% | -5.01 | −42.5M |
| FY2019 | – | – | −28.1M | –% | -13.15 | −29.0M |
| FY2018 | – | – | −9.3M | –% | -4.78 | −19.1M |